IRIS
RECCHIUTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.937
EU - Europa 1.335
AS - Asia 789
AF - Africa 12
OC - Oceania 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.896
SG - Singapore 279
CN - Cina 244
IE - Irlanda 244
IT - Italia 226
SE - Svezia 216
UA - Ucraina 181
TR - Turchia 134
GB - Regno Unito 125
DE - Germania 96
FR - Francia 82
IN - India 71
FI - Finlandia 48
RU - Federazione Russa 41
CA - Canada 28
AT - Austria 24
VN - Vietnam 20
HK - Hong Kong 13
BE - Belgio 12
BZ - Belize 12
EG - Egitto 10
NL - Olanda 10
AU - Australia 9
IR - Iran 8
ES - Italia 7
BR - Brasile 6
CZ - Repubblica Ceca 6
JP - Giappone 6
KR - Corea 4
IL - Israele 3
PL - Polonia 3
PT - Portogallo 3
TW - Taiwan 3
HR - Croazia 2
MA - Marocco 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
LT - Lituania 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
Totale 4.092
Salva come PNG Salva come JPEG
Città #
Chandler 366
Singapore 245
Dublin 242
Jacksonville 228
Princeton 109
Ashburn 98
Dearborn 94
Southend 88
Izmir 77
Ann Arbor 74
Wilmington 66
Nanjing 62
New York 60
Boardman 56
Santa Clara 52
Beijing 46
Altamura 41
Chieti 40
Rome 32
Woodbridge 32
Houston 29
Cambridge 28
San Mateo 22
Washington 22
Augusta 21
Nanchang 21
Vienna 21
Los Angeles 19
Dong Ket 17
Helsinki 16
Munich 15
Montreal 14
Nuremberg 13
Brussels 12
Central 12
Falls Church 12
Shenyang 11
Toronto 11
Jiaxing 10
Cairo 9
Seattle 9
Ascoli Piceno 8
Lappeenranta 8
Kunming 7
Tianjin 7
Changsha 6
Jinan 6
Milan 6
Naples 6
Redwood City 6
Shanghai 6
Hangzhou 5
Hebei 5
Melbourne 5
Norwalk 5
Prato 5
Tokyo 5
Amsterdam 4
Brno 4
Düsseldorf 4
Frederick 4
Grevenbroich 4
Jundiaí 4
Leawood 4
Napoli 4
Pescara 4
Rochester 4
Saint-Saens 4
Alba 3
Auburn Hills 3
Dacun 3
Lanciano 3
Modena 3
Phoenix 3
Saskatoon 3
Taizhou 3
Tappahannock 3
Woburn 3
Aprilia 2
Belgrade 2
Belo Horizonte 2
Campobasso 2
Carinola 2
Chaoyang 2
Chicago 2
Delhi 2
Denver 2
Edinburgh 2
Frankfurt Am Main 2
Fuzhou 2
Guangzhou 2
Hanoi 2
Hefei 2
Islington 2
Lanzhou 2
Louisville 2
Ness Ziona 2
Ningbo 2
Orange 2
Piotrkow Trybunalski 2
Totale 2.666
Salva come PNG Salva come JPEG
Nome #
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 140
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 131
Establishment and long-term culture of human cystic fibrosis endothelial cells 129
Mechanisms of endothelial cell dysfunction in cystic fibrosis 128
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 110
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 105
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. 105
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. 104
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 104
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 101
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 100
Lipoxins, resolvins, and the resolution of inflammation 99
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 97
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 95
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 94
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. 93
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 92
Lipoxin receptors 90
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 90
Novel anti-inflammatory--pro-resolving mediators and their receptors. 89
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 89
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 87
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 86
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 84
Epigenetic regulation of the formyl peptide receptor 2 gene 82
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 81
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 80
Homocysteine modulates the CD40/CD40L system 80
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 77
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 76
RESOLVINS, LIPOXINS, AND MARESINS IN RESOLUTION OF INFLAMMATION 75
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 73
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 72
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 71
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 71
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. 70
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 69
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 68
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 68
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 68
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 67
Targeting caveolin-1 deficiency in bone marrow derived cells: A new therapeutic window for fibrotic diseases? 65
Resolvin D1 and its GPCRs in resolution circuits of inflammation. 62
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 59
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 58
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 55
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. 53
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 49
The Resolution Approach to Cystic Fibrosis Inflammation 49
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 41
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 37
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 35
Specialized pro-resolving lipid mediators and resolution of viral diseases 25
Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease 24
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 20
Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease 20
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 16
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 15
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 14
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 13
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease 12
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 11
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 11
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 11
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 10
Nrf2 Plays a Key Role in Erythropoiesis during Aging 6
Totale 4.461
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 0 0 0 63 89 48 31 90 67 8
2020/2021453 39 9 55 20 33 67 15 14 109 46 15 31
2021/2022344 5 10 2 88 15 11 6 22 19 15 26 125
2022/2023958 72 133 61 105 88 170 49 64 146 12 32 26
2023/2024649 54 32 37 26 35 193 97 55 7 29 19 65
2024/2025663 74 241 147 53 85 63 0 0 0 0 0 0
Totale 4.461